welbournes

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers MSN/2025/057 Tier 2 – medium impact Date of issue: 20/10/2025 Mometasone (Asmanex Twisthaler®) 200microgram/dose dry powder inhaler (60 dose) is being discontinued from late October 2025. [...]

The post Medicine Supply Notification: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (16/10/2025) confirmed the following initial list of price concessions for October 2025: Drug Pack size Price concession Amiodarone 100mg tablets 28 £2.74 Amiodarone 200mg tablets 28 £6.05 Co-careldopa 12.5mg/50mg tablets 90 £5.97 Co-careldopa 25mg/100mg tablets 100 £8.38 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.80 Dutasteride [...]

The post October 2025 Price Concessions 1st Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Dalivit® Oral Drops MSN/2025/055 Tier 2 – medium impact Date of issue: 15/10/2025 Dalivit® Oral Drops are out of stock until further notice. Abidec® Multivitamin Drops remain available and can support increased demand. A copy of this [...]

The post Medicine Supply Notification: Dalivit® Oral Drops appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]

The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen. MSN/2025/054 Tier 2 – medium impact Date of issue: 15/10/2025 Exenatide (Bydureon® BCise®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pens have been discontinued with supplies now exhausted. [...]

The post Medicine Supply Notification: Exenatide (Bydureon® BCise® ) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen appeared first on Community Pharmacy England.